What studies use adaptor-based modular cancer immunitherapy?
Best insight from top research papers
Adaptor-based modular cancer immunotherapy has been studied in several papers. Arndt et al. discuss the different adaptor CAR platforms available and their potential in addressing the challenges of conventional CAR therapy, such as safety and antigen escape . Metelitsa et al. describe the use of molecular adaptors in configuring immune effector cells for cancer immunotherapy, including the production of molecular adaptors with tumor cell binding domains and cytokine domains . Zhong presents compositions and methods for immunotherapy using a modular CAR (mCAR) and a precision molecular adaptor (PMA) for targeting CAR-T cells to tumor antigens . Jiang et al. propose an immunomodulating nano-adaptor (imNA) that can integrate the functions of monoclonal antibodies (mAbs) and chimeric antigen receptor-T cells, enhancing antitumor immune responses . Rader et al. develop a targeting device based on the formation of a covalent bond between a small synthetic molecule and an antibody molecule, demonstrating its potential for cancer immunotherapy .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| The paper does not mention any specific studies that use adaptor-based modular cancer immunotherapy. | |
44 Citations | The provided paper discusses the use of immunomodulating nano-adaptors (imNAs) in cancer immunotherapy. It does not specifically mention studies that use adaptor-based modular cancer immunotherapy. |
| The paper does not mention any specific studies that use adaptor-based modular cancer immunotherapy. The paper is about a precision molecular adaptor system for CAR-T immunotherapy. | |
| The paper does not specifically mention any studies that use adaptor-based modular cancer immunotherapy. | |
Patent 26 Apr 2018 1 Citations | The paper does not specifically mention any studies that use adaptor-based modular cancer immunotherapy. |
Related Questions
Does modeling the tumor microenvironment help in cancer immunotherapy?5 answersModeling the tumor microenvironment is crucial for advancing cancer immunotherapy. The tumor microenvironment plays a pivotal role in tumor growth, progression, and response to therapy by influencing cell interactions, immune responses, and therapy resistance. Utilizing 3D models like spheroids and organoids allows for a more accurate representation of the complex interactions within the tumor microenvironment compared to traditional 2D models or animal studies. These models enable researchers to study the effects of immunomodulatory treatments, test combination therapies, and understand the dynamics of the tumor-immune microenvironment. By mimicking the tumor microenvironment, these models provide valuable insights into tumor evolution, metastasis, and therapy resistance, ultimately aiding in the development of more effective and personalized cancer immunotherapies.
Could CIN tumours activate the adaptive immune system?4 answersCIN tumours have the ability to activate the adaptive immune system. Tumour-associated antigens (TAAs) trigger the immune response by activating T cells via major histocompatibility complex (MHC). Additionally, the adaptive immune response in breast cancer plays a role in tumour eradication, with cytotoxic T lymphocytes and T helper type 1 cells inducing tumour eradication. Furthermore, therapeutics based on the adaptive immune system have shown promise in fighting tumours, as cell death-mediated events regulate adaptive immune responses within tumours. Carcinogens can also affect the immune system, with interference in cell-mediated immunity being one example. These findings suggest that CIN tumours can activate the adaptive immune system, leading to potential immunotherapeutic approaches for tumour eradication.
Can immunotherapy be used to treat cancer?4 answersImmunotherapy is a type of cancer treatment that harnesses the power of the immune system to recognize and attack cancer cells. It involves manipulating the immune response to either suppress or stimulate it, and is currently being used as a promising method for treating cancer. Efforts to use the body's own anti-tumor response have led to the discovery of alternative treatments for cancer. Immunotherapy focuses on boosting the body's own immune response against cancer tumors. A new approach to immunotherapy involves "rewiring macrophages," which could offer a fresh boost to cancer immunotherapy. Therefore, immunotherapy can be used to treat cancer by stimulating the immune system to recognize and attack cancer cells more effectively.
Cancer vaccines using VLPs4 answersCancer vaccines using Virus-like particles (VLPs) have been developed for various types of cancer. VLPs have been successfully used as a therapeutic approach for tumor cells due to their ability to trigger anti-viral responses and affect immune cells. Different platforms, such as yeasts, bacteriophage, mammalian cells, and insect cells, have been employed to create VLP variants with different functions. VLPs derived from HBsAg and MrNV have shown therapeutic effects in the treatment of hepatocellular carcinoma (HCC). CuMBTT VLPs have played a major role in preventing B16F10 melanomas in skin cancer. MS2 VLPs have demonstrated great efficiency in treating Xct-related breast cancer, while GPI-anchored VLPs have shown efficacy in HER2-triggered breast cancer. VLPs have also been used as a vaccine platform for melanoma B16-ovalbumin growth control, showing promising results in both prophylactic and therapeutic settings. Capsid VLPs (cVLPs) have been identified as a promising antigen delivery system for cancer vaccines, offering advantages such as high production yields and low cost. VLP-based technology has been extensively studied for the development of cancer vaccines, including breast cancer.
How to design modular software for robots?5 answersModular software for robots can be designed using a variety of methods. One approach is to utilize machine learning techniques, such as generative adversarial networks (GANs), to create a one-to-many mapping from a given task to a distribution of designs. Another method involves employing a genetic algorithm to evolve robotic structures and a reinforcement learning algorithm to train their behavior and evaluate their potential learning ability. Additionally, a modular skill-based software framework can be used to achieve flexible composition of a robot's skills based on the actual situation. Deep reinforcement learning can also be utilized to efficiently search the space of modular robot designs for given tasks. Furthermore, ISO standardization work has been carried out to formulate guidelines for service robot modularity, providing a framework for the development of open plug-n-play modules that can be easily assembled to create application-specific robots.
What are the types of adaptive designs used in vaccine development?5 answersAdaptive designs used in vaccine development include adaptive trial designs with features such as Bayesian designs, master protocol strategy, Real-World-Data (RWD) embedded trials, and the correlate of protection framework. Genomic approaches have also been used to understand the role of genetic variants in immune responses and to design better vaccines. Synthetic attenuated virus engineering (SAVE) is a novel approach to vaccine design that has been used to attenuate viruses such as polioviruses, influenza viruses, HIV retroviruses, and Streptococcus pneumonia. Adaptive designs in clinical trials, including adaptive dose-finding trials, adaptive interim analyses, and adaptive randomization, have also been applied in vaccine development. Additionally, statistical methods have been developed to adapt initial vaccine development plans to sequential information accumulated during the development process.